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Use of recombinant antigens to detect antibodies against
Mycoplasma suis, with correlation of serological results to
hematological findings
Abstract
Porcine eperythrozoonosis is a disease with worldwide distribution caused by the unculturable
hemotrophic bacterium Mycoplasma suis. Current serological testing utilizes crude M. suis antigens
purified from the blood of experimentally infected pigs. These antigens show high variability and are
restricted to specialized laboratories. We evaluated a novel serological assay based on two recombinant
M. suis antigens (rMSG1 and rHspA1). Antigen specificity was proven by means of sera raised against
nonhemotrophic mycoplasma and other relevant bacteria. Using experimental and convalescent-phase
sera, rMSG1 and rHspA1 enzyme-linked immunosorbent assays (ELISAs) demonstrated sensitivities,
specificities, and predictive values (94.0 to 100.0%) equal to or higher than those of the M. suis
whole-cell ELISA. Field samples from 120 weaning piglets grouped by quantitative PCR results were
used to evaluate the diagnostic capability of the new ELISA systems in comparison to that of the
whole-cell ELISA. Assuming a 100.0% specificity of the PCR, the whole-cell ELISA, rHspA1 ELISA,
and rMSG1 ELISA showed specificities of 84.8%, 83.8%, and 90.6% and sensitivities of 61.5%, 74.0%
and 58.1%, respectively. Cohen's kappa coefficients comparing the recombinant ELISAs to the
whole-cell ELISA indicate moderate to substantial agreement. The detection of anti-MSG1 and/or
anti-HspA1 antibodies in pigs was significantly correlated with decreased hematocrit, erythrocyte
numbers, and hemoglobin concentrations, indicating that a single seropositive result is connected with
clinical and etiological significance. In conclusion, rMSG1 and rHspA1 are sensitive and specific
serological and infection markers which are for the first time used independently of animal experiments.
They are especially fit to be used in routine diagnosis, pathogenesis studies, and large-scale
epidemiological investigations.
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Porcine eperythrozoonosis is a disease with worldwide distribution caused by the unculturable hemotrophic
bacterium Mycoplasma suis. Current serological testing utilizes crude M. suis antigens purified from the blood
of experimentally infected pigs. These antigens show high variability and are restricted to specialized labora-
tories. We evaluated a novel serological assay based on two recombinant M. suis antigens (rMSG1 and
rHspA1). Antigen specificity was proven by means of sera raised against nonhemotrophic mycoplasma and
other relevant bacteria. Using experimental and convalescent-phase sera, rMSG1 and rHspA1 enzyme-linked
immunosorbent assays (ELISAs) demonstrated sensitivities, specificities, and predictive values (94.0 to
100.0%) equal to or higher than those of the M. suis whole-cell ELISA. Field samples from 120 weaning piglets
grouped by quantitative PCR results were used to evaluate the diagnostic capability of the new ELISA systems
in comparison to that of the whole-cell ELISA. Assuming a 100.0% specificity of the PCR, the whole-cell ELISA,
rHspA1 ELISA, and rMSG1 ELISA showed specificities of 84.8%, 83.8%, and 90.6% and sensitivities of 61.5%,
74.0% and 58.1%, respectively. Cohen’s kappa coefficients comparing the recombinant ELISAs to the whole-cell
ELISA indicate moderate to substantial agreement. The detection of anti-MSG1 and/or anti-HspA1 antibodies
in pigs was significantly correlated with decreased hematocrit, erythrocyte numbers, and hemoglobin concen-
trations, indicating that a single seropositive result is connected with clinical and etiological significance. In
conclusion, rMSG1 and rHspA1 are sensitive and specific serological and infection markers which are for the
first time used independently of animal experiments. They are especially fit to be used in routine diagnosis,
pathogenesis studies, and large-scale epidemiological investigations.
Mycoplasma suis is the etiological agent of porcine eperyth-
rozoonosis (PE), a bacterial infection reported worldwide that
manifests as a severe and often life-threatening acute febrile
icteroanemia mainly in piglets, pregnant sows immediately
prepartum, and feeder pigs under stress (13). In addition to
acute PE attacks, chronic low-grade M. suis infections, which
vary from asymptomatic infections to a range of clinical con-
ditions including (i) anemia, mild icterus, and unthriftiness in
newborns, (ii) growth retardation in feeder pigs, and (iii) poor
reproductive performance in sows, can occur (2, 13, 19). All in
all, due to the reduced performance of the pigs, increased
susceptibility to respiratory and enteric diseases, and increased
use of antimicrobials, M. suis causes the pig industry serious
economic losses.
Since M. suis cannot be cultured in vitro, laboratory diagnosis is
difficult. Serological testing methods have not been widely used
even where the application of M. suis-specific serological tests
would allow for a cost-effective diagnosis on a herd basis, fol-
low-up investigations, and extensive prevalence studies. Previous
studies applied three different methods: (i) a complement fixation
assay (1, 14, 16), (ii) an indirect hemagglutination assay (15), and
(iii) whole-cell enzyme-linked immunoassays (ELISAs) (5, 9, 14).
All these tests require animal experiments for the acquisition of
partially purified antigens from the blood of experimentally in-
fected pigs. Although previous studies have shown that immuno-
globulin (Ig) depletion of blood-derived antigens increased the
specificity of theM. suisELISA significantly (5), the application of
serological assays for the routine diagnosis of M. suis remained
difficult. All serodiagnostic antigens described to date share the
intrinsic disadvantage of extreme variability among batches and
restriction to specialized laboratories because of the necessity of
animal experiments. Therefore, an accurate adoption and stan-
dardization of diagnostic serological procedures with whole-cell
M. suis antigens is impossible. Hence, recombinant antigens seem
to be a good alternative substitute for blood-derived M. suis an-
tigens and may overcome the difficulties encountered in using
experimental animals as a source of M. suis. The recombinant
Escherichia coli expression of proteins would allow the production
of reproducible and characterized antigenic proteins for unculti-
vable mycoplasmas.
Recently two immunodominant M. suis proteins (p40 and
p70) were identified as promising serological markers (5). De-
tailed identification and characterization of these proteins (p40
and p70) were achieved using serological proteome analysis
and genomic library screening procedures: p70 was identified
as HspA1, a surface-localized DnaK-analogous protein (6),
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and p40 was identified as MSG1, a surface-localized adhesion
protein with glyceraldehyde-3-phosphate dehydrogenase prop-
erties (7).
The aim of this study was to develop and evaluate the first
recombinant serological assay for detecting M. suis-specific
antibodies. To this effect, we investigated the antibody re-
sponses and kinetics of experimentally infected pigs with im-
munoblotting and indirect ELISA, using the purified recombi-
nant HspA1 and MSG1 proteins (rHspA1/rMSG1) produced
in Escherichia coli. Furthermore, we evaluated the diagnostic
application of rMSG1 and rHspA1 and the combination of
both for the detection of antibodies against M. suis in field
samples and compared them with a whole-cell M. suis ELISA
(5), PCR results, and hematological parameters.
MATERIALS AND METHODS
Bacterial strains, plasmids, and control sera.M. suis strain 54/96 was obtained
from experimentally infected pigs as described previously (4, 5). E. coli K12
strains Top10 and LMG194 (Invitrogen, Basel, Switzerland) were grown in
Luria-Bertani broth containing 100 g/ml ampicillin and used to clone and
express the M. suis a1 and msg1 genes. The arabinose-inducible expression
plasmid pBadmycHis (N-terminal six-His and Myc tag; Invitrogen) was used for
protein expression. Experimental sera from rabbits and pigs immunized/infected
with nonhemotrophic Mycoplasma spp. and pig-associated bacteria are specified
in Table 1.
Experimental M. suis infection in pigs. Pigs (n  25; group 1) were experi-
mentally infected with M. suis strain 54/96 as described previously (5). Briefly, 5-
to 6-week-old splenectomized piglets were used in this study. Experimental
infection was carried out by subcutaneous inoculation of 1 ml of EDTA-antico-
agulated blood containing 109/ml M. suis cells. Pigs were monitored daily for
clinical signs of acute eperythrozoonosis (e.g., temperature) and were treated
with tetracyclines (20 mg/kg of body weight) at the peak of bacteriemia as
determined by means of microscopic examination of acridine orange-stained
blood smears. Blood samples were collected on day 7 of the study and on day
0, just before inoculation with M. suis. Sera from eight pigs were collected at
weekly intervals over a period of 14 weeks. Serum samples from the remaining
pigs were collected 4 weeks after inoculation. Sera from mock-infected animals
(inoculation of blood from M. suis-negative pigs; group 2) were taken accord-
ingly. All animal experiments described were undertaken under animal experi-
ment approvals (Government Office of Upper Bavaria, Germany, and Cantonal
Veterinary Office of Zurich, Switzerland).
Pig sera. Four other groups of sera were established. Group 3 contained sera
from 25 pigs exhibiting typical clinical PE symptoms. The pigs were examined at
the Clinic for Swine, University of Munich. Blood samples were investigated by
means of PCR. Group 4 contained negative-control sera from 25 healthy pigs
(PCR negative). Other blood and serum samples from individual pigs were
obtained from slaughterhouses. Blood samples were screened by using a quan-
titative LightCycler PCR (8) and separated into two groups, i.e., into M. suis-
positive (group 5; n  60) and M. suis-negative (group 6; n  60) sera.
DNA extraction and PCR assay. DNA was extracted from 200 l of EDTA-
anticoagulated blood using the Bacterial Genomic DNA kit (Sigma, Buchs,
Switzerland). M. suis-specific real-time PCR (LC PCR) was carried out based on
an assay described previously (8).
M. suis whole-cell ELISA. Pig sera were serologically investigated using IgG-
depleted, blood-derived antigens as described previously (5).
Hematological analysis. Hematological parameters of the pigs of group 5 and
group 6 were evaluated with EDTA-anticoagulated blood, using the Scil Vet
ABC tool (Scil Animal Care Company GmbH; Viernheim, Germany); biochem-
ical parameters of blood sera were analyzed by means of the Hitachi 911 chem-
istry analyzer (Roche, Mannheim, Germany).
Production of recombinant proteins MSG1 and HspA1. To circumvent the
Mycoplasma-specific translational barrier of the UGA codon, the genes encoding
HspA1 (gene a1) and MSG1 (gene msg1) were adapted to the codon usage of E.
coli and de novo synthesized as described previously (6, 7). Recombinant E. coli
clones were grown in RM base medium (Invitrogen) supplemented with 100
g/ml ampicillin to an optical density at 600 nm (OD600) of 0.6 at 37°C. Recom-
binant protein synthesis was induced by the addition of 0.02% arabinose, and E.
coli cultures were incubated for a further 2 h at 37°C. His-tagged fusion proteins
were purified as described previously (6, 7). The purities of the recombinant
proteins were analyzed using sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE) and Coomassie blue staining. Protein concentrations
were determined using a Bradford assay kit (Bio-Rad, Reinach, Switzerland).
SDS-PAGE and immunoblotting. SDS-PAGE was performed according to
standard procedures (11). Separated proteins were transferred onto nitrocellu-
lose membranes, using a semidry electrophoretic transfer cell (Trans Blot; Bio-
Rad, Reinach, Switzerland). Immunoblots were probed with E. coli adsorbed
sera from experimental pigs diluted to 1:100 in phosphate-buffered saline (PBS)
with 2% skim milk powder. Immunoreactive proteins were visualized by using
horseradish peroxidase-labeled goat anti-pig IgG (Sigma) as secondary antibod-
ies and 4-chloro-1-naphthol as the chromogenic reagent.
Recombinant-antigen ELISA. Polystyrene microtiter plates (Greiner, Nu¨rtin-
gen, Germany) were coated at 4°C overnight with rMSG1, rHspA1, or the
purified E. coli control, 0.5 to 300 ng/well suspended in 0.05 M sodium carbonate
(pH 9.6). The plates were washed three times with PBS–0.05% Tween 20 (vol/
vol) (PBST), blocked with PBST containing 1% Proteose peptone (Difco-Brun-
schwig, Basel, Switzerland) for 1 h at room temperature, and after three washes
with PBST, stored at 20°C until use. All incubation steps listed below were
performed in a 100-l volume for 1 h at room temperature and under agitation.
Wells were incubated with sera, diluted 100-fold in blocking solution, and then
washed three times with PBST and incubated with anti-pig IgG conjugated to
horseradish peroxidase (heavy plus light chains; Sigma). The plates were then
washed three times with PBST and incubated with 2,2-azinobis(3-ethylbenzthia-
zolinesulfonic acid (Roche Diagnostics, Rotkreuz, Switzerland) for 30 min in the
dark. The adsorbence at 405 nm was measured using a computer-assisted mi-
croplate reader (Tecan, Maennedorf, Switzerland).
Initial assays were performed to determine the antigen concentration that best
distinguished between ELISA reactions of serum samples from M. suis-infected
pigs and those of samples from mock-infected control pigs. Checkerboard titra-
tions were performed with serial twofold antigen dilutions (starting concentra-
tion, 1 g) and with twofold serum dilutions (25-, 50-, 100-, and 200-fold). In
subsequent assays, the plates were coated with the predetermined optimal anti-
gen concentration and E. coli control antigen. Incubations were performed with
100- and 10,000-fold dilutions of sera and secondary antibody conjugate, respec-
tively. Individual sera were tested in duplicate with recombinant proteins and the
E. coli control. The means of the net OD values (ODrMSG1/ODrHspA1 
ODE. coli) were calculated for analysis. Paired measurements differing by more
than 10% were tested once again. Positive and negative control sera were in-
cluded on each plate and in duplicate. To determine the serostatus of the
slaughterhouse pig groups (groups 5 and 6), separate ELISAs for each recom-
binant protein were performed and results from the individual ELISAs were
combined.
Cutoff values for each recombinant protein were calculated as the mean net
OD value for the sera from 25 mock-infected animals plus three times the
standard deviation. Test specificity (the minimum number of false-negative re-
sults) was assessed with sera from PCR-negative, mock-infected experimental
pigs ( “true negative”). The percent specificity was calculated from the follow-
ing equation: [number of true negatives/(number of true negatives  number of
false positives)]  100. The test sensitivity was assessed using sera from exper-
imentally M. suis-infected pigs ( “true positive”). The percent sensitivity was
calculated using the following equation: [number of true positives/(number of
true positives  number of false negatives)]  100. Diagnostic efficiency was
defined as follows: (number of true positives  number of true negatives)/all test
TABLE 1. Experimental sera used for antigen specificity testing
Bacterial species Animalspecies Source
Mycoplasma hyopneumoniae Pig J. Freya
Mycoplasma hyorhinis Pig J. Frey
Actinobacillus pleuropneumoniae Pig C. Baumsb
Chlamydia suis Pig IVBc
Chlamydophila abortus Pig IVB
Salmonella enterica subsp. enterica
serovar Choleraesuis
Rabbit IVB
Escherichia coli Rabbit IVB
a Institute of Veterinary Bacteriology, University Berne, Bern, Switzerland.
b Institute for Microbiology, University of Veterinary Medicine Hannover,
Hannover, Germany.
c Institute of Veterinary Bacteriology, University Zurich, Zurich, Switzerland.
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results. The negative predictive value was calculated as follows: number of true
negatives/(number of true negatives  number of false negatives). The positive
predictive value was calculated as follows: number of true positives/(number of
true positives  number of false positives).
Data analysis. Parameters (ELISA OD values, PCR results, and blood pa-
rameters) were compiled and analyzed using Excel (Microsoft, Wallisellen, Swit-
zerland), Origin 7.5 (Redacom), and SigmaStat 3.5 (Statcon) software. Param-
eters between serologically positive and serologically negative pigs were
compared using the Mann-Whitney test. The correlations between M. suis blood
loads and blood parameters were assessed by using contingency table analysis to
determine relationships between diagnostic methods. P values of 0.05 were
considered to be significant. Cohen’s kappa coefficients were calculated to com-
pare results of whole-cell ELISA with those of recombinant ELISAs. Interpre-
tation of the kappa values was performed as suggested by Landis and Koch (12).
Kappa values of 0.20 or less indicate a slight compliance; 0.21 to 0.40, fair
agreement, 0.41 to 0.60, moderate agreement, 0.61 to 0.80, substantial agree-
ment, 0.81, almost perfect agreement, and 1.00, perfect agreement between
tests.
To estimate the efficiencies of the three ELISAs and the PCR tests with field
samples, a latent class model using maximum-likelihood techniques was used. It
was assumed that the PCR test had a diagnostic specificity of 100% but that the
sensitivity of the PCR, the sensitivity and specificity of the ELISA tests, and the
number of true-positive samples from the 120 field samples were unknown.
Correlation dependence on the sensitivities and specificities of the tests was
assumed and included in the model (3). With a known specificity of the PCR, the
model was definable even in the presence of multiple dependencies between the
diagnostic tests. Starting values of each test, sensitivity and specificity, the pop-
ulation prevalence, and the correlation values of the tests were determined. Each
animal was assigned a probability calculated from these starting values and the
combination of test results seen for each animal. Each probability was converted
to a negative logarithm and summed to give the negative logarithm of the
likelihood of the data. Parameters were varied using the solver function of Excel
to calculate the parameter values that minimized the negative log likelihood. To
estimate confidence intervals, a likelihood profile (17) was calculated using the
PopTools add-on (CSIRO) of Excel.
RESULTS
Setting-up of recombinant serological assay. SDS-PAGE
and Coomassie brilliant blue staining confirmed a high purity
of recombinant protein preparations with only marginal un-
specific protein bands (Fig. 1A). Immunoblot analysis with
pooled sera from experimentally infected pigs confirmed the
immunoreactivities of both proteins: the serum pool recog-
nized the expected recombinant proteins rHspA1 and rMSG1
with molecular masses of approximately 40 kDa and 70 kDa,
respectively, but did not react with the noninduced control
preparation (Fig. 1B). Pooled sera from negative-control pigs
did not react with rHspA1 or with rMSG1 (Fig. 1C).
All ELISA procedures were optimized with regard to anti-
gen concentrations and serum dilution. Antigen titration ex-
periments revealed that 0.6 g/ml of rMSG1, 0.3 g/ml of
rHspA1, and a serum dilution of 1:100 produced the best
resolution between the ODs of the positive and negative serum
pools. The ELISA cutoff value for each recombinant protein
was calculated as the mean net OD of the mock-infected group
sera plus thrice the standard deviation (Table 2).
Serum samples from pigs experimentally infected with M.
suis (n  25; group 1), from naturally infected pigs with symp-
toms typical for PE (n  25; group 3), and from M. suis-free,
mock-infected animals (n  25; group 2) and samples from
clinically healthy, PCR-negative pigs (n  25; group 4) were
used to test the performance of the M. suis recombinant serol-
ogy assays. To exclude antibody reactions against E. coli com-
ponents in the purified recombinant antigens, all sera were
adsorbed with E. coli cells and additionally tested against E.
FIG. 1. (A) SDS-PAGE of recombinant MSG1 and HspA1, showing the purity after affinity chromatography preparation. (B and C) Immu-
noblot analysis of recombinant MSG1 and HspA1; blots were detected with a serum pool of experimentally M. suis-infected pigs (B) or with a
serum pool of M. suis-negative pigs (C). MW, molecular mass standard; Ec, E. coli control preparation.
TABLE 2. Diagnostic performance of recombinant ELISAs in comparison with that of M. suis whole-cell ELISAa
Serological test Cutoff value
b
(OD405)
Diagnostic
sensitivityc (%)
Diagnostic
specificityd (%)
Diagnostic
efficiencye (%) PPV
f (%) NPVg (%)
rMSG1 ELISA 0.213 94.0 100.0 97.0 100.0 94.3
rHspA1 ELISA 0.259 100.0 94.0 97.0 94.3 100.0
Whole-cell ELISA 0.273 94.0 96.0 93.0 95.9 94.1
a These results were obtained from experimentally infected acutely diseased pigs and from mock-infected experimental animals and healthy pigs.
b Cutoff values were calculated as the mean net OD value for the sera from mock-infected animals plus three times the standard deviation.
c Sensitivity was calculated as follows: number of true positives/(number of true positives  number of false negatives)	  100.
d Specificity was calculated as follows: number of true negatives/(number of true negatives  number of false positives)	  100.
e Diagnostic efficiency was defined as follows: (number of true positives  number of true negatives)/all test results	  100.
f Positive predictive value (PPV) was defined as follows: number of true positives/(number of true positives  number of false positives)	  100.
g Negative predictive value (NPV) was calculated as follows: [number of true negatives/(number of true negatives  number of false negatives)]  100.
1618 HOELZLE ET AL. CLIN. VACCINE IMMUNOL.
coli as the antigen. All adsorbed sera showed no reactions with
E. coli antigens in immunoblots and low OD values in the
ELISA (data not shown). Different adsorption profiles were
tested for their application suitabilities. An adsorption proce-
dure using 100 l serum with a serum predilution of 1:25, an E.
coli cell pellet volume of approximately 50 l, and an adsorp-
tion time of 2 h was found to produce a sufficient adsorption
effect.
The ELISA reactivities of each individual experimental se-
rum sample with the two recombinant proteins are shown in
Fig. 2. For comparison purposes, the results obtained with the
whole-cell M. suis ELISA (5) are also shown. A comparison of
the performances of the rMSG1 and rHspA1 ELISAs com-
pared with those of the whole-cell ELISA is summarized in
Table 2. Overall, the test sensitivities (the minimum number of
false-negative results in groups 1 and 3) of the recombinant-
antigen ELISAs were equal to or higher than the whole-cell
ELISA sensitivity (94.0% and 100.0%, respectively, compared
to 94.0%). In terms of the test specificities (the minimum
number of positive results in groups 2 and 4), both recombi-
nant ELISAs were also comparable to the whole-cell ELISA
(100.0% and 94.0%, respectively, compared to 96.0%). The
well-to-well variations of the rMSG1 and rHspA1 ELISAs
were determined to be 6.5% and 8.2%, respectively. Further-
more, both recombinant ELISAs were shown to have a mean
interassay variation of 20.6%. To determine the antigen spec-
ificity with control animals, experimental sera from animals
immunized or infected with nonhemotrophic Mycoplasma spp.
and other pig-related bacteria (Table 1) were tested. Both
recombinant antigens showed an antigen specificity of 100.0%,
since antibodies raised against other Mycoplasma species and
other pig-related bacteria did not react with rHspA1 or MSG1
in any case.
Antibody kinetics measured against M. suis recombinant
proteins. To analyze the kinetics of the antibody responses to
rMSG1 and rHspA1, ELISAs were performed with a total of
120 serum samples obtained from 8 experimentally infected
pigs (group 1 animals) between days 0 and 98. Representative
rHspA1 and rMSG1 antibody kinetics are shown in Fig. 3. All
preinfection sera were negative for rMSG1 and rHspA1 reac-
tivities. HspA1- and MSG1-specific antibodies were detected
as early as 2 weeks postinfection, and all pigs were identified as
antibody responders within 3 weeks postinfection until the end
of the experiment. Only at the time of the major acute clinical
PE symptoms did the ELISA OD values with both antigens
and the pig-derived M. suis antigen decline significantly and
partly below the cutoff values.
Diagnostic applicability of rMSG1 and rHspA1 ELISAs.
Applicability and discriminatory efficacy of the recombinant
serology assays were evaluated using serum samples randomly
collected from 120 weaning piglets at a slaughterhouse. Prior
to serological testing, the pigs were grouped into PCR-positive
(n  60) and PCR-negative (n  60) animals. The results of
the ELISAs (whole cell, rMSG1, rHspA1, and the combination
of rMSG1 plus rHspA1) are shown in Table 3.
FIG. 2. Serological results for M. suis-positive pigs (circles; exper-
imentally infected and diseased pigs) and control pigs (blank triangles;
mock-infected and healthy, PCR-negative pigs). Results are shown for
both recombinant antigens (rMSG1, 60 ng/well; rHspA1, 30 ng/well)
in comparison to the M. suis whole-cell (Ms) ELISA. Adsorbance
(OD405) values are shown for reactions with serum samples diluted
100-fold. Cutoff values for each antigen are indicated as dashed line.
FIG. 3. Representative antibody kinetics for one experimental pig,
using three different ELISAs, is presented. Sequential sera from an M.
suis-infected pig collected pre- and postinoculation were incubated
with blood-derived Ig-depleted M. suis antigen (Ms ELISA) or the
recombinant protein rMSG1 or rHspA1. Net optical densities (OD405)
were measured. During acute PE (weeks 4 and 7, indicated by arrows),
low levels of ELISA reactivities with the M. suis antigen and both
recombinant proteins were monitored.
TABLE 3. Diagnostic application of recombinant ELISAs in
investigation of field samplesa
Animal group (nb)
No. (%) of serologically positive pigs with assay using:
rMSG1 rHspA1 rMSG1 rHspA1
Whole
cellc
PCR-positive
pigs (60)
35 (58.3) 45 (75.0) 48 (80.0) 37 (61.7)
Bacterial load
of 105/ml
blood (15)
11 (73.3) 13 (86.6) 14 (93.3) 11 (73.3)
Bacterial load
of 105/ml
blood (45)
24 (53.3) 32 (71.1) 34 (75.5) 26 (57.7)
PCR-negative
pigs (60)
8 (13.3) 12 (20.0) 16 (26.7) 11 (18.3)
a Results were obtained by investigating 60 sera from PCR-positive animals
and 60 sera from PCR-negative animals.
b n, no. of pigs.
c M. suis whole-cell antigen.
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Analysis of the results obtained with all four different
ELISAs showed a clearly higher detection rate for the group of
PCR-positive pigs than for the group of PCR-negative pigs. In
detail, 35 (58.3%) sera out of the 60 PCR-positive pigs tested
positive with rMSG1 ELISA. Forty-five (75.0%) tested positive
with rHspA1, and 48 (80.0%) tested positive using both
rMSG1 and rHspA1 as antigens. By means of the whole-cell
ELISA, 37 of 60 PCR-positive animals were judged to be
positive (61.7%). In greater detail, 11 (73.3%) of the 15 ani-
mals showing an M. suis load by PCR of 105 per ml blood
tested positive with rMSG1, 13 (86.6%) tested positive with
rHspA1, and 14 (93.3%) revealed a positive serological result
using both rMSG1 and rHspA1 as antigens. In this group of
animals, 11 pigs (73.3%) were tested as M. suis antibody re-
sponders by means of the whole-cell ELISA. In the group of
PCR-positive pigs showing bacterial loads of less than 105 per
ml blood (n  45), 24 (53.3%) samples reacted positively with
rMSG1, 32 (71.1%) reacted positively with rHspA1, and 34
(75.5%) reacted positively using rMSG1 in combination with
rHspA1. Twenty-six (57.7%) reacted positively in the whole-
cell ELISA. In the group of PCR-negative pigs (n  60), eight
pigs (13.3%) were identified as M. suis positive in the rMSG1
ELISA and 12 pigs (20%) tested positive in the rHspA1
ELISA, and in the combinatorial rMSG1/rHspA1 ELISA, 16
pigs (26.6%) were positive. Using the whole-cell ELISA, sam-
ples from 11 pigs (18.3%) reacted as serologically positive.
Comparison of the different ELISAs. Diagnostic values of
the serological assays were obtained by comparison of the
different ELISA results with PCR results. If quantitative LC
PCR is considered the reference test, the estimated M. suis
prevalence in the 120 abattoir samples was 54.0% (95% con-
fidence interval [CI], 50.0% to 65.0%), with 65 pigs having a
positive infection status (95% CI, 60 to 78 pigs). Then, the
quantitative LC PCR had a sensitivity of 93.6% (95% CI, 77.0
to 100.0%), assuming that the specificity was 100.0%. Out of all
three different ELISAs, the rHspA1 ELISA showed the high-
est sensitivity at 74.0% (95% CI, 61.7 to 84.2%) and the
rMSG1 ELISA the highest specificity at 90.6% (95% CI, 79.2
to 98.0%). In comparison, sensitivity and specificity of the
whole-cell ELISA were estimated to amount to 61.5% (95%
CI, 49.2 to 72.9%) and 84.8% (95% CI, 72.0 to 95.0%), re-
spectively. Combined testing with both antigens revealed de-
pendence on the sensitivity of the rMSG1 and rHspA1 ELISA
of 0.09 (95% CI, 0.043 to 0.145).
When the results of the rMSG1 ELISA were compared to
those from the whole-cell ELISA, we observed an agreement
of 80.0% and a Cohen’s kappa coefficient of 0.52, indicating a
moderate agreement. The comparison of the rHspA1 ELISA
results to those from the whole-cell ELISA revealed an agree-
ment of 82.5% and a Cohen’s kappa coefficient of 0.71, indi-
cating a substantial agreement.
Hematological characteristics of pigs testing serologically
positive for M. suis. Correlation between the presence of anti-
HspA1 and anti-MSG1 antibodies and the hematological sta-
tus of pigs was analyzed. Of the hematological parameters
evaluated, three parameters were significantly associated with
a serologically positive status for M. suis. M. suis-serologically
positive pigs had significantly lower packaged cell volume, he-
moglobin, and red-blood-cell values (P  0.05). The mean
values, 95% confidence intervals, and ranges for these param-
eters are provided in Table 4. No significant association be-
tween erythrocytic indices, i.e., mean cellular volume, mean
cellular hemoglobin, and mean cellular hemoglobin concentra-
tion, and the serological status of the pigs was found. Likewise,
no significant association could be evaluated between leuko-
cyte, serum glucose, bilirubin, and iron values and the serolog-
ical status of the pigs examined.
DISCUSSION
Serological assays are inexpensive, easy-to-perform diagnos-
tic tests which are applied in a great range of microbiological
routine laboratories. Their overall quality depends on the
choice and high class of the antigens used for antibody detec-
tion. All serological M. suis assays described formerly have the
intrinsic disadvantage of employing complex and undefined M.
suis antigens obtained from the peripheral blood of experimen-
tally infected pigs that contains uncontrollable amounts of
porcine components (e.g., porcine Igs) (1, 5, 9, 14, 15, 16).
Serological assays based on recombinant antigens are the only
possibility for circumventing these drawbacks. Recombinant
protein-based serological tests may achieve high sensitivity and
TABLE 4. Hematological findings for serologically M. suis-positive and -negative pigsa
Blood parameter
Value for pigs with serological status of:
Reference
ranged P value
ePositiveb Negativec
Median 95% CI Median 95% CI
PCVf (%) 32.9 31.9–33.9 34.6 33.3–35.9 32–42 0.039*
Hemoglobin (mmol/liter) 6.3 6.1–6.5 6.7 6.4–7.0 6.6–8.3 0.023*
Erythrocytes (106/l) 6.3 6.1–6.6 6.9 6.6–7.1 5.8–7.8 0.015*
Leukocytes (103/l) 26.8 24.6–28.7 28.9 26.1–31.6 13–24 0.19
Serum glucose (mmol/liter) 3.7 3.3–4.1 4.1 3.7–4.4 3.8–6.7 0.15
Bilirubin (mol/liter) 3.4 2.5–4.4 3.4 2.6–4.3 4.3 0.99
Iron (mol/liter) 17.0 15.2–18.7 17.3 15.1–19.5 
17.2 0.83
a Pigs from the slaughterhouse groups (group 5 and group 6).
b Samples from serologically positive animals reacted positively with rMSG1 or rHspA1 or with both recombinant antigens.
c Samples from serologically negative animals were negative with both rMSG1 and rHspA1.
d Reference ranges according to Kixmoeller and coworkers (10).
e Asterisks indicate P values of 0.05, which were considered significant.
f PCV, packaged cell volume.
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specificity because of the high concentration of immunoreac-
tive antigens and the lack of nonspecific moieties found in
whole-cell preparations from the blood of experimentally in-
fected pigs. An ideal antigen would be a principal target of the
host immune response (serodiagnostic markers of infection),
expressed by M. suis during acute and chronic disease and
conserved among M. suis isolates. In addition, differentiation
between autoreactive serological reactions directed against
porcine constituents and agent-specific seroreactivities should
be easily possible given the fact that the type and intensity of
the immune response (M. suis-specific versus autoreactive) ob-
viously play a major role in the course of the hemoplasma
infection and the development of disease (5, 18).
In previous studies, we identified two M. suis proteins with
such features, i.e., HspA1 and MSG1 (5, 6, 7). Within the
scope of this study, we evaluated serological assays based on
these two proteins expressed in E. coli. Purity and seroreactiv-
ity of both recombinant proteins were proven in SDS-PAGE
and immunoblot studies. The analytical specificity of the two
recombinant antigens was confirmed by testing rabbit and pig
sera induced against nonhemotrophic mycoplasma species of a
different origin but related to M. suis and against other micro-
organisms with clinical relatedness. We did not detect any
cross-reactivity in immunoblot and ELISA analyses in any of
the aforementioned cases.
The investigation of sera from experimentally infected pigs
with the novel recombinant ELISA demonstrated high speci-
ficities and sensitivities and a high agreement with the whole-
cell M. suis ELISA. In addition, the kinetics of the immune
response in the course of experimentally induced PE was con-
firmed using rHspA1 and rMSG1. Typically, during acute clin-
ical PE, a derailment of the M. suis-specific antibody response
was accompanied by peaking levels of autoreactive IgG anti-
bodies (5). The derailment of M. suis-specific antibodies was
also observed using recombinant proteins as antigens. There-
fore, the problem of detecting M. suis-specific antibodies dur-
ing clinical acute PE was not resolved by means of using re-
combinant antigens. This phenomenon is obviously to be
traced back not to the antigen used but to a derailment of the
immune response during acute PE (5).
Our results demonstrate that both antigens are suitable for
diagnostic assays. In comparison, rHspA1 showed a higher
sensitivity with a lower specificity, whereas rMSG1 showed a
higher specificity combined with a lower sensitivity. Therefore,
an assay combining both antigens could prove to be a good
alternative: in our study, the parallel application of both anti-
gens to classify pigs as positive or negative enhanced the sen-
sitivity. Moreover, this antigen combination is considered to be
appropriate because investigations of the M. suis-specific im-
mune response in the course of infection revealed a very het-
erologous antibody profile by means of the detected antigens
(5). Nevertheless, the combination of two immunodominant
M. suis antigens (HspA1 and MSG1) allowed us to detect both
acutely and chronically infected pigs.
A reference test (gold standard) for the detection of anti-
bodies directed against M. suis with which the ELISA results
could be compared is not available. Therefore, the establish-
ment of the infectious status of the pigs was performed on the
basis of quantitative PCR results. Negative sera were collected
from experimental pigs free of M. suis as tested by PCR.
Positive sera were collected from pigs infected experimentally
that tested positive for infections (PCR and clinical investiga-
tion). The examination of these well-defined groups by means
of both recombinant ELISAs yielded high specificities and
sensitivities (94.0 to 100.0%). To evaluate the diagnostic ap-
plicability, field sera from slaughtered pigs were grouped by
investigating the corresponding anticoagulated blood speci-
mens using real-time PCR (8). In the group of PCR-positive
piglets, the ratio of serologically positive piglets was signifi-
cantly higher (58.3 to 75.0%) than that in the group of PCR-
negative piglets (13.3 to 26.6%). When the results of recom-
binant ELISAs were compared to those of the whole-cell
ELISA, we observed considerable levels of agreement (80.0%
and 82.5%; kappa values, 0.52 and 0.71, respectively). It must
be noted that the use of both recombinant ELISA results as a
diagnostic criterion means that the two tests are not condition-
ally independent (both tests measure anti-M. suis antibodies).
Combinatorial testing with rMSG1 and rHspA1 as diagnostic
antigens revealed a correlation of sensitivity of 0.09 (CI, 95%;
range, 0.043 to 0.145) and the highest sensitivity (80.0% posi-
tive in the group of PCR-positive animals).
The significance of a positive serological result with rHspA1
or/and rMSG1 as antigens could be proved by a significant
correlation between the result of the serology and the clinical
hematological parameters, i.e., pigs showing antibodies against
M. suis also revealed significantly lowered values of packed cell
volume, hemoglobin, and RBC numbers. The absence of
significant differences in erythrocytic indices (mean cellular
volume, mean cellular hemoglobin, and mean cellular hemo-
globin concentration) are indicative for a normochromic, nor-
mocytic anemia due to intravascular hemolysis. However, at
this point, we do not know whether intra- or extravascular
hemolysis predominates during M. suis infections (18), and the
analysis of hemolysis mechanisms during M. suis infections
should be the goal of further studies. In addition, we discov-
ered a greater ratio of pigs with bacterial loads higher than 105
per ml in the group of seropositive piglets.
Remarkably, antibodies against M. suis were detected in
approximately 20% of the piglets in the PCR-negative group.
At first sight, these results seem to speak in favor of a false-
positive serology. However, all sera were reanalyzed using im-
munoblots against whole-cell M. suis antigens and against the
recombinant proteins, and the seropositivity could thus be con-
firmed in practically all cases (data not shown). Therefore, it is
obvious that our serological assay enables the detection of
seropositive animals after clearance of the infection or the
detection of chronic low-grade infections which cannot be rec-
ognized by PCR or by microscopy. These carrier pigs are of
major economic significance, as well as being important with
regard to epidemiology, surveillance, and the eradication of
PE. Altogether, the new M. suis serological assays are a very
valuable completion of our diagnostic possibilities for M. suis
infections, especially in addition to PCR.
To date, no serological test for PE has achieved integration
into routine diagnostic laboratories. The serological assays cur-
rently available are inadequate for routine work because they
can be carried out only in those few laboratories able to prop-
agate M. suis in splenectomized pigs and therefore able to
prepare diagnostic antigens. Our new recombinant ELISA will
contribute to rectifying this problem. The robustness of our
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serological assays, reflected by the low intra- and interassay
coefficients of variation of 6.5 to 8.2% and 20.6%, respectively,
provide further evidence for this. Arguments against the ap-
plication of recombinant antigens in serology are protein sta-
bility, lack of sensitivity due to only a few antigens of the agent
being used, and E. coli impurities which can be traced back to
insufficient purification procedures. Within the scope of our
work, the stability of the recombinant proteins proved to be
very high (approximately 6 months at 80°C). We determined
a similar sensitivity in comparison to results with whole-cell
antigens, and as mentioned, our rHspA1 and rMSG1 antigens
were quite pure. Nevertheless, an adsorption of the investi-
gated sera with E. coli was unavoidable. Because an adsorption
of the prediluted sera (1:25) over a period of about 2 h proved
to be sufficient to remove cross-reacting antibodies, it should
be possible to perform this additional task in routine labora-
tories.
In summary, this article describes for the first time the de-
velopment of a serodiagnostic assay for PE based on antigens
produced in the laboratory. The use of the recombinant pro-
teins MSG1 and HspA1 has important advantages, i.e., (i)
improved specificity, sensitivity, reproducibility, and reliability
of PE serodiagnosis, (ii) replacement of animal experiments
necessary to propagate M. suis for antigen production, (iii) the
possibility of extensive prevalence and surveillance studies de-
termining the actual impact of M. suis infection in pig popu-
lations, and (iv) studies on the connection between the M. suis
immune response and PE pathogenesis.
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